Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Howard Greene Insider Profile
4 Followers
Howard Greene, Director at Tandem Diabetes Care, holds 30.00K shares in Tandem Diabetes Care (Ticker: TNDM). Most recently, Howard Greene Sold $10,000 shares of Tandem Diabetes Care on Aug 06, 2019 for an estimated value of 615.04K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+144.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Howard Greene holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 13, 2018 - Feb 13, 2019
Return:+800.00%
The most profitable trade made by Howard Greene
Howard Greene's Trading History
List of latest transactions for each holding click on a transaction to see Howard Greene's performance on stock
You May Also Like
Howard Greene insider profile FAQ
What is the percentage of profitable transactions made by Howard Greene?
The percentage of profitable transactions made by Howard Greene is 40%.
What is the average return per transaction made by Howard Greene?
The average return per transaction made by Howard Greene is 144.80%.
What stocks does Howard Greene hold?
Howard Greene holds: TNDM stocks.
What was Howard Greene’s latest transaction?
Howard Greene latest transaction was an Informative Sell of $615.04K.
What was Howard Greene's most profitable transaction?
Howard Greene’s most profitable transaction was an Informative Buy of TNDM stock on February 13, 2018. The return on the trade was 800.00%.
What is Howard Greene's role in Tandem Diabetes Care?
Howard Greene's role in Tandem Diabetes Care is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.